Navigation Links
Ganeden Biotech Granted 100th Probiotic Patent
Date:10/14/2010

CLEVELAND, Oct. 14 /PRNewswire/ -- Ganeden Biotech, Inc., maker of the patented probiotic strain GanedenBC30®, recently announced the granting of the company's 100th patent, which expands the use and scope of the GanedenBC30® probiotic to help prevent lactic-acid bacteria and to better improve digestive and immune health.  

The 100th patent comes in the wake of Ganeden's latest collaboration with Organic Milling marking a milestone for the company as it continues to develop new product partnerships with some of the world's most innovative food and product manufacturers.  

From Bigelow® Tea and Red Mango to Guernsey Farms Dairy and Agostoni Chocolate, Ganeden's range of products and partnerships is a testament to the versatility and durability of their probiotic strain Bacillus coagulans GBI-30, 6086 branded as GanedenBC30®, which has the unique ability to survive the harsh manufacturing process and still be activated in the body.  This is attributed to the naturally occurring layer of organic material that protects the genetic core of the bacteria throughout the manufacturing and digestion process.

"The 100th patent approval is a true accomplishment for us, as it reflects the extent of our innovation and collaboration since the GanedenBC30® probiotic was first developed and patented just a little over a decade ago," said Sean Farmer, Chief Scientific Officer and co-founder of Ganeden Biotech. Farmer is credited with discovering the GanedenBC30® probiotic and has written each subsequent patent since helping co-found the company in 1997.  "We ow
'/>"/>

SOURCE Ganeden Biotech, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Ganeden Biotech Introduces the First Probiotic Thin Strip
2. Ganeden Biotech Introduces GanPro(TM) Direct-Fed Microbial for Livestock
3. Ganeden Biotech, Liquid Health Labs Unveil New Drink Technology
4. Ganeden Biotech and Heartland Sweeteners to Produce Probiotic Sweetener
5. Ganeden Biotech Receives Frost & Sullivan Probiotics Product Innovation Award
6. Genesis Biopharma to Present at the Informed Investors Forum Biotech, Healthcare & Pharma Virtual Conference on October 13
7. Reportlinker Adds the Top 10 Biotechnology Companies: Positioning, Performance and SWOT Analyses
8. Trius to Participate in Antibiotics Panel Discussion at Citis 5th Annual Biotech Day
9. Maven Biotechnologies Receives $1.96 Million From the National Institutes of Health (NIH) to Develop Their LFIRE™ Label-Free Detection Technology for Proteomics
10. Biotech Posts Strong Third Quarter Performance as Capital Markets Go on a Tear
11. Kibow Biotech Releases Results of Pilot Scale Study of Its Probiotic Formulation for Kidney Health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... 29, 2014 Intrinsic Imaging, an ... GAMP® 5 compliant imaging core lab, announced today ... II clinical trial to assess a new treatment ... trial, Intrinsic Imaging will provide comprehensive imaging core ... and charter development, site qualification, site training and ...
(Date:8/28/2014)... “This kit has an improved extraction efficiency and ... 150 ppb,” said Mark Tess, PhD, Mycotoxin Product Manager for ... owners and USDA-GIPSA inspection agencies that have a need to ... place in a matter of minutes with nothing but our ... feed and grain before accepting it, but they no longer ...
(Date:8/28/2014)... Grove, PA (PRWEB) August 28, 2014 ... and create a culture that will allow individuals to ... are becoming increasingly important for employers looking to compete ... science industries are embracing this trend, as the sector ... fabric of a company, which will have real results ...
(Date:8/28/2014)... 2014  Armetheon, Inc. ( www.armetheon.com ), a ... late-stage cardiovascular drug candidates, today announced that it ... of financing. The Series A round was co-led ... participation from investors that included Atheneos Capital and ... Larry Hsu , the founder of Impax Laboratories. ...
Breaking Biology Technology:Intrinsic Imaging Awarded Phase II Clinical Trial to Assess New Treatment for Non-Hodgkin’s Lymphoma 2Klein Hersh International Leads Philadelphia Area Life Science Industry in Company Culture 2Klein Hersh International Leads Philadelphia Area Life Science Industry in Company Culture 3Armetheon Completes $7.0 Million Series A Financing 2Armetheon Completes $7.0 Million Series A Financing 3
... Quark Pharmaceuticals, Inc.,a development-stage pharmaceutical ... (RNAi)-based therapeutics, today announced the,presentation of ... Europe, taking place,September 16-18, 2008 in ... Mett, Hagar Kalinski, and Hagit Ashush, ...
... WALTHAM, Mass., Sept. 17 Repligen Corporation,(Nasdaq: RGEN ... Officer, Walter C. Herlihy, Ph.D., will present at the ... 2008 at 1:00,p.m. EDT at the Grand Hyatt Hotel, ... audio-webcast of the presentation will be available via,Repligen,s website ...
... CITY, Sept. 17 /PRNewswire-FirstCall/ - AEterna Zentaris Inc.,(NASDAQ: ... company focused on,endocrine therapy and oncology, today announced ... Dennis Turpin, CA, will present a,company overview at ... Conference on Tuesday, September 23, 2008 at 3:25 ...
Cached Biology Technology:Quark Pharmaceuticals Announces Poster Presentations at RNAi Europe 2008 2Quark Pharmaceuticals Announces Poster Presentations at RNAi Europe 2008 3Repligen to Present at the 2008 UBS Global Life Sciences Conference Wednesday, September 24th, 1:00 p.m. EDT 2Repligen to Present at the 2008 UBS Global Life Sciences Conference Wednesday, September 24th, 1:00 p.m. EDT 3
(Date:8/28/2014)... expansion of marine protected areas is needed to protect ... to investigators from the Wildlife Conservation Society and other ... saving the largest numbers of species, often at the ... ecological functions. , Many vital ecological functions ... also are food for millions of people. This ...
(Date:8/28/2014)... (August 28, 2014) Researchers at the University of ... muscular dystrophy (FSHD) to be used for muscle regeneration ... potential therapies for FSHD. , The research is published ... Reports . , There is no treatment for FSHD, ... common type of muscular dystrophy. FSHD is an unusual ...
(Date:8/28/2014)... that could positively impact the global battle ... thanks to researchers in Penn State,s College ... made from the seaweed-derived food ingredient carrageenan ... provides a woman-initiated, drug-delivery vehicle that can ... infections during unprotected heterosexual intercourse, the researchers ...
Breaking Biology News(10 mins):Study finds marine protected areas inadequate for protecting fish and ocean ecology 2UMN researchers find animal model for understudied type of muscular dystrophy 2Sensory-tested drug-delivery vehicle could limit spread of HIV, AIDS 2Sensory-tested drug-delivery vehicle could limit spread of HIV, AIDS 3
... ON, CANADA -- Because Wisconsin and Ontario are similar ... produced, climate, and latitude, researchers in Ontario looked to ... climate on vegetable crop yield. According to researchers from ... the growing season is similar in the two locations, ...
... some entomologists, an apparent paradox exists: Despite choosing a ... spiders which range from mild disgust to extreme arachnophobia. ... of American Entomologist features the results of ... questions about their fear of spiders. Although most entomologists ...
... scientists, led by researchers from the University of Geneva (UNIGE),s ... today present a map that points to the genetic causes ... and Nature Biotechnology , offers the largest-ever dataset ... RNA. , Understanding how each person,s unique genome makes them ...
Cached Biology News:Weather, yield compared for horticultural crops in Wisconsin, southern Ontario 2Arachnophobic entomologists: When 2 more legs make a big difference 2Functional genetic variation in humans: Comprehensive map published 2
Because it is manufactured at our ISO 9001–certified facilities in Eugene, Oregon, we can guarantee that FluoroPure grade propidium iodide is greater than or equal to 98% pure by HPLC....
MOUSE ANTI GUINEA PIG T-CELLS (PAN):FITC Immunogen: Guinea pig peritoneal T-cells...
Prepared in 0.85% saline....
RABBIT ANTI HUMAN CYTOCHROME P450 1A1/2 Immunogen: Purified human CYP1A2 expressed in E.Coli ...
Biology Products: